Scienza e Tecnologia
3D Cell Culture Market worth US$2.26 billion by 2030 with 11.7% CAGR | MarketsandMarkets™
the 3D cell culture market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures. Scaffold-based 3D cell cultures dominated the market, with the highest share in 2024. Scaffold-based 3D cell culture is a promising new technology used for a variety of applications, including drug discovery, tissue engineering, and regenerative medicine. Increased adoption of this technology across various industries is likely to have a positive influence on market growth.
the 3D cell culture market is segmented into pharmaceutical & biotechnology companies, research institutes, the cosmetics industry, and other end users. Pharmaceutical & biotechnology companies accounted for the largest share of the 3D cell culture market in 2024. Increase in demand for 3D cell culture in the development of various drug candidates is the key contributor to the segment's dominance.
the 3D cell culture market is segmented into North America , Europe , Asia Pacific , Latin America , Middle East , and Africa . North America accounted for the largest share of the 3D cell culture market. This leadership is driven by the region's high healthcare expenditure and substantial investments in life sciences research, enabling rapid adoption of advanced culture technologies. The strong presence of pharmaceutical and biotechnology companies' fuels demand for 3D models in drug discovery, toxicology studies, and personalized medicine. Regulatory and funding support from organizations such as the National Institutes of Health (NIH) further accelerates the transition from 2D to physiologically relevant 3D systems. Key players, including Thermo Fisher Scientific Inc. (US), Corning Incorporated (US), and Avantor Inc. (US), have a strong regional presence, ensuring innovation and commercialization of advanced culture platforms. Prominent academic institutions, such as Harvard University (US) and Massachusetts Institute of Technology (US), act as pioneers in validating and scaling emerging 3D applications. In addition, a favorable funding and collaboration environment supports adoption across hospitals, biotech firms, and research centers, reinforcing North America's dominant position in the global market.
The 3D cell culture market is consolidated. The prominent players operating in this market include Thermo Fisher Scientific Inc. (US), Merck KGaA ( Germany ), Corning Incorporated (US), Lonza ( Switzerland ), Tecan Trading AG ( Switzerland ), Avantor, Inc. (US), and REPROCELL Inc. ( Japan ), among others. The key players of this market are mostly focusing on collaborations, acquisitions, partnerships, agreements, expansion, and advancements in 3D cell culture technology.
Thermo Fisher Scientific Inc. remains a key player in the 3D cell culture market in 2024, supported by its comprehensive and diversified product portfolio, broad geographic presence, and balanced focus on organic and inorganic growth strategies. In 2024, the company expanded its portfolio by launching advanced 3D cell culture solutions to enhance cancer and stem cell research applications. Thermo Fisher continues to prioritize innovation through significant investments in research and development, ensuring the delivery of cutting-edge technologies that align with the evolving demands of the scientific community. The company's robust global distribution network further strengthens product accessibility and customer engagement, enabling the company to deliver reliable and scalable 3D cell culture solutions. This integrated strategic approach reinforces Thermo Fisher's leadership in the 3D cell culture landscape.
Merck KGaA stands out as a leading player in the 3D cell culture market in 2024, demonstrating a strong commitment to research and development, dedicating significant resources to innovation to advance 3D cell culture applications across research and biopharmaceutical development. Merck's extensive global distribution network further strengthens accessibility and customer support, enabling the delivery of reliable and high-quality 3D cell culture solutions. This multifaceted approach firmly positions Merck as a key provider in the 3D cell culture landscape. With its strong R&D capabilities and product portfolio, the company is expected to maintain its leading position in the market.
For more information,
Get access to the latest updates on and
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, , and . With a , we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our , which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/3d-cell-culture-market-worth-us2-26-billion-by-2030-with-11-7-cagr--marketsandmarkets-302575571.html